,,ii  #aafth ,,congress  #ast ,session  
,s4 #bgea  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,october #cj1  
#bjai,mr4 ,cornyn 7for himself1 ,ms4    
,sinema1 ,mrs4 ,hyde-,smith1 and ,mr4   
,jones7 introduced the following bill2  
which was read twice and referred to the
 ,committee on ,finance  ,a ,,bill  ,to 
amend title ,,xviii of the ,social      
,security ,act to improve access to     
innovative new medical devices furnished
 to individuals with end stage renal    
disease under part ,b of the ,medicare  
program by establishing a new device    
add-on payment adjustment under such    
part4  #a4 ,short title ,this ,act may  
be cited as the ,patient ,access to     
,,esrd ,new ,innovative ,devices ,act4  
#b4 ,findings ,congress finds the       
following3 7#a7 ,there are approximately
 #djj1jjj ,medicare beneficiaries with  
end-stage renal disease1 making up #a   
percent of the ,medicare population but 
accounting for approximately #g percent 
of all ,medicare spending4  7#b7        

,expected remaining lifetime for        
dialysis patients under #hj years old is
 one-third as long as their counterparts
 without ,,esrd1 and for dialysis       
patients over #hj years old1 it is      
one-half as long as that of their       
counterparts without ,,esrd4  7#c7 ,on  
average1 hemodialysis patients are      
hospitalized nearly twice per year and  
about #cj percent have an unplanned     
rehospitalization within the #cj days   
following discharge1 contributing to    
high costs for treating ,,esrd ,medicare
 beneficiaries4  7#d7 ,there is a lack  
of innovative new devices for ,,esrd    
,medicare beneficiaries1 in part because
 of the lack of reimbursement incentives
 for novel devices4  #c4 ,increasing    
patient access to innovative devices for
 the treatment of ,,esrd ,as part of the
 promulgation of the annual rule for the
 ,medicare end stage renal disease      
prospective payment system under section
 #ahha7;b77#ad7 of the ,social ,security
 ,act 7#db ,u4,s4,c4 #acierr7b77#ad77   

for calendar year #bjba1 the ,secretary 
of ,health and ,human ,services 7in this
 section referred to as the ,secretary7 
shall establish a process to provide--  
7#a7 a #c-year temporary add-on payment 
adjustment for a new medical device     
approved by the ,food and ,drug         
,administration under section           
#eac7;f77#b7 or section #eae of the     
,federal ,food1 ,drug1 and ,cosmetic    
,act 7#ba ,u4,s4,c4 #cfj;c1 #cfj;e7 on  
or after ,january #a1 #bjbj1 that       
provides meaningful clinical improvement
 and is furnished to a beneficiary for  
the diagnosis1 treatment1 or management 
of end stage renal disease2 and  7#b7   
for such adjustment to be implemented in
 a nonbudget neutral manner under       
section #ahha7;b77#ad74